Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

In vitro Release Characteristics of Nitroglycerin from Microemulsion-Based Hydrogel System for Anal Fissure Treatment

  • Published : 2007.04.21
Download PDF
⟨ Previous Next ⟩

Abstract

To develop topical nitroglycerin (NTG) preparation far chronic anal fissure treatment, the release rate of NTG should be controlled carefully. For this, microemulsion was prepared from the phase diagram construction with Cremophor ELP, ethanol and Labrafil $M1944CS^{(R)}$ and the topical gel was prepared by dispersing NTG containing microemulsion into hydrophilic polymers. in viかo release characteristics were evaluated with Franz diffusion cell using cellulose membrane and compared with control hydrogels. The release rate of NTG was followed $1^{st}$ order kinetics and, when comparing the NTG release from control hydrogel with that from the microemulsion-based hydrogel, the NTG release rate was controlled by the content of polymers within continuous phase and the concentration of dispersed phase.

Keywords

References

  1. S. A. Imtiaz, J. B. Karen and M. Andrew, Impact of preoperative intravenous nitroglycerin on in-hospital outcomes after coronary artery bypass grafting for unstable angina, Am. Heart J., 148, 727-732 (2004) https://doi.org/10.1016/j.ahj.2004.04.003
  2. U. Elkayam, F. Bitar, M. W. Akhter, S. Khan, S. Patrus and M. Derakhshani, Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations, Cardiovasc. Pharmacal. Ther., 9, 227-241. (2004) https://doi.org/10.1177/107424840400900403
  3. U. Stenestrand, J. Lindback and L Wallentin, Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction, Am. Heart J., 149, 82-90 (2005) https://doi.org/10.1016/j.ahj.2004.07.018
  4. Merck index 11th Ed., Merck&Co. Inc., Rahway, N.J. U.S.A pp. 1045 (1989)
  5. http://en.wikipedia.org/wiki/Nitroglycerin
  6. M. R. Nabih and M. B. Thomas, New and future migraine therapy, Pharmacal. Ther., 112, 199-212 (2006) https://doi.org/10.1016/j.pharmthera.2005.04.010
  7. R. A. Kloner, Pharmacology and Drug Interaction Effects of the Phosphodiesterase 5 Inhibitors: Focus on ${\alpha}$-Blocker Interactions, The Am. J. Cardiol., 96, Supplement 2, 42-46 (2005)
  8. A. MacLean, Chemical Sphincterotomy in the treatment of anal fissure, J. Gastro. Surg., 10, 629-630 (2006) https://doi.org/10.1016/j.gassur.2006.01.006
  9. R. S. McLeod and J. Evans, Symptomatic care and nitroglycerin in the management of anal fissure, J. Gastrointest. Surg., 6, 278-280 (2002) https://doi.org/10.1016/S1091-255X(01)00078-6
  10. M. J. Utzig, A. J. Kroesen and H. J. Buhr, Concepts in pathogenesis and treatment of chronic anal fissure-A review of the literature, Am. J. Gastroenterol., 98, 968-974 (2003)
  11. I. Lindsey, O. M. Jones, C. Cunningham and N. J. M. Mortensen, Chronic anal fissure, Br. J. Surg., 91, 270-279 (2004) https://doi.org/10.1002/bjs.4531
  12. USP NF 23rd Ed., The United States Pharmacopeial Convention Inc., U.S.A. pp. 1090 (1994)
  13. U. Thadani and T. Rodgers, Side effects of using nitrates to treat angina., Expert. Opin. Drug Saf Expert., 5, 667-674 (2006) https://doi.org/10.1517/14740338.5.5.667
  14. A. C. Sintov and L. Shapiro, New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo, J. Controlled Rel., 95, 173-183 (2004) https://doi.org/10.1016/j.jconrel.2003.11.004
  15. A. C. Sintov and S. Botner, Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems, Int. J. Pharm., 311, 55-62 (2006) https://doi.org/10.1016/j.ijpharm.2005.12.019
  16. P. Spiclin, M. Homar, A. Zupani- Valant and M. Gasperlin, Sodium ascorbyl phosphate in topical microemulsions, Int. J. Pharm., 256, 65-73 (2003) https://doi.org/10.1016/S0378-5173(03)00063-2
  17. M. Trotta, Influence of phase transformation on indomethacin release from microemulsions, J. Controlled Rel., 60, 399-405 (1999) https://doi.org/10.1016/S0168-3659(99)00094-2
  18. M. R. Gasco, M. Gallarate, M. Trotta, L. Bauchiero, E. Gremmo and O. Chiappero, Microemulsions as topical delivery vehicles: ocular administration of timolol, J. Pharm. Biomed. Anal., 7, 433-439 (1989) https://doi.org/10.1016/0731-7085(89)80030-5
  19. M. Trotta, M. R. Gasco and S. Morel, Release of drugs from oil-water microemulsions, J. Controlled Rel., 10, 237-243 (1989) https://doi.org/10.1016/0168-3659(89)90073-4
  20. P. P. Constantinides, Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res., 12, 1561-1570 (1995) https://doi.org/10.1023/A:1016268311867
  21. E. A. Mueler, F. M. Kovarik, J. B. van Bree, W. Tetzloff, J. Grevel and K. Kutz, Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation, Pharm Res., 11, 301-304 (1994) https://doi.org/10.1023/A:1018923912135